Mulmit

Krystal Biotech, Inc.Krystal Biotech, Inc.

KRYS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31389,130,000161,295,000204,831,0006.84
2024-12-31290,515,00065,748,00089,159,0003
2023-12-3150,699,000-109,617,00010,932,0000.39
2022-12-310-145,196,000-139,975,000-5.49
2021-12-310-68,275,000-69,570,000-3.13

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-14ROSSI DINO A3,691
2026-08-14ROSSI DINO A341
2026-08-14ROSSI DINO A2,287
2026-08-14ROSSI DINO A5,226
2026-08-14ROSSI DINO A1,687
2026-08-14ROSSI DINO A7,428
2026-08-14ROSSI DINO A4,896
2026-08-14ROSSI DINO A3,095
2026-08-14ROSSI DINO A40
2026-06-25Thomas John CharlesEVP, General Counsel1,000
2026-06-25Thomas John CharlesEVP, General Counsel1,000
2026-06-25Thomas John CharlesEVP, General Counsel1,000

8-K events

FiledItems
2026-08-03Results of operations · Financial statements and exhibits
2026-07-21Other events · Financial statements and exhibits
2026-05-20Submission of matters to a vote
2026-05-04Financial statements and exhibits
2026-02-17Results of operations
2026-01-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-01-08Regulation FD disclosure · Financial statements and exhibits
2025-12-23Officer or director change · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.